Skip to main content
ATOS
NASDAQ Life Sciences

Atossa Q3 Loss Narrows to $5.6M as Cash Falls to $20.6M

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.15
Mkt Cap
$21.256M
52W Low
$1.7
52W High
$14.85
52W Position info
26% above low
Off High info
86% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ATOS sits 26% above its 52-week low of $1.7.

Summary

Atossa posted a Q3 2026 net loss of $5.6 million, or $0.56 per share, narrower than the $8.7 million ($1.01) loss a year earlier, as total operating expenses fell to $5.9 million from $9.3 million. Cash and equivalents dropped to $20.6 million at September 30 from $41.3 million at year-end 2025, leaving a thin runway for a clinical-stage company with no revenue. The quarter's news flow was dominated by the stapled CVR agreement giving holders 25% of net proceeds from a first priority review voucher, capped at $50 million — but no PRV has been awarded and the company says there is no assurance one will be. Near-term value hinges on FDA IND clearance for (Z)-endoxifen in DMD and MAS, expected by early 2027, with Phase 2 trials starting later that year. Karisma follow-up and I-SPY2 data are due at the San Antonio Breast Cancer Symposium in December 2026, and EVANGELINE Phase 2 topline is expected in Q2 2027.

At the time of this announcement, ATOS was trading at $2.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.3M. The 52-week trading range was $1.70 to $14.85. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

ATOS - Latest Insights

ATOS
Nov 10, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $2.03 info
Change: -$0.120 (-6%) info
Market Cap: $20.258M info
ATOS
Oct 09, 2026, 8:13 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $2.03 info
Change: -$0.370 (-15%) info
Market Cap: $20.258M info
ATOS
Aug 07, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.38
Real-time Price: $2.03 info
Change: -$0.350 (-15%) info
Market Cap: $20.258M info
ATOS
Aug 07, 2026, 8:45 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.38
Real-time Price: $2.03 info
Change: -$0.350 (-15%) info
Market Cap: $20.258M info
ATOS
Aug 07, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.45
Real-time Price: $2.03 info
Change: -$0.420 (-17%) info
Market Cap: $20.258M info